Remove 2008 Remove Chronic Pain Remove Clinical Trials Remove Patients
article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

She placed 4th in the triathlon at the 2000 Sydney Olympics and won the 2008 Ironman 70.3 She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). Nearly half of the athletes reported either acute or chronic pain. Study co-author Joanna Zeiger, MS, Ph.D.

article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

She placed 4th in the triathlon at the 2000 Sydney Olympics and won the 2008 Ironman 70.3 She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). Nearly half of the athletes reported either acute or chronic pain. Study co-author Joanna Zeiger, MS, Ph.D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression. Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life.

THC 144
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

Chronic migraines can make it incredibly challenging to hold down a job. The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally.

Terpenes 132
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). The review, however, did not cover patient access to medicinal cannabis. Conclusions.